CCM
ELV icon

Camber Capital Management’s Elevance Health ELV Stock Holding History

Camber Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-700,000
Closed -$75.3M – 40
2014
Q2 		$75.3M Sell
700,000
-100,000
-13% -$10.3M 4.94% 3
2014
Q1 		$79.6M Hold
800,000
– – 6.24% 3
2013
Q4 		$73.9M Sell
800,000
-50,000
-6% -$4.44M 6.52% 4
2013
Q3 		$71.1M Buy
850,000
+50,000
+6% +$4.29M 7.45% 4
2013
Q2 		$65.5M Buy
+800,000
New +$59.9M 6.73% 2

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Camber Capital Management's ELV Position: Q3 2014 in Review

Camber Capital Management sold out of Elevance Health (ELV) in Q3 2014, closing a stake of 700,000 shares — an estimated $75.3M sold.

Camber Capital Management first reported a position in ELV in Q2 2013 and held it in 5 quarters. The position peaked at $79.6M in Q1 2014. 708 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

  • Camber Capital Management reported no remaining Elevance Health position as of Q3 2014 after selling out during the quarter.
  • Camber Capital Management sold 700,000 Elevance Health shares in Q3 2014, an estimated $75.3M.
  • Camber Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 5 quarters.
  • Camber Capital Management's Elevance Health position peaked at $79.6M in Q1 2014.
  • 708 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on Camber Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.